Brad Sleebs
17Patents
7h-index
47Co-inventors
62Inventor score
Filing activity: Oct 16, 2007 → Nov 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8114893B2 | Compounds and methods of use | Chemistry; Metallurgy | 42 | Active |
| US8168645B2 | Arylsulfonamide compounds | Human Necessities | 31 | Active |
| US8518970B2 | Compounds and methods of use | Chemistry; Metallurgy | 28 | Active |
| US8232273B2 | Heterocyclic compounds and methods of use | Chemistry; Metallurgy | 26 | Active |
| US8293737B2 | Anxiolytic compounds | Human Necessities | 10 | Active |
| US8551990B2 | Anxiolytic compounds | Human Necessities | 7 | Active |
| US8614212B2 | Anxiolytic compounds | Human Necessities | 7 | Active |
| US8906912B2 | Anxiolytic compounds | Human Necessities | 5 | Active |
| US9067928B2 | Compounds and methods of use | Chemistry; Metallurgy | 5 | Active |
| US9023848B2 | Small-molecules as therapeutics | Chemistry; Metallurgy | 4 | Active |
| US9573945B2 | Anxiolytic compounds | Human Necessities | 3 | Active |
| US9975892B2 | Anxiolytic compounds | Human Necessities | 1 | Active |
| US10954231B2 | Anxiolytic compounds | Human Necessities | 1 | Active |
| US10233181B2 | Anxiolytic compounds | Human Necessities | 1 | Active |
| US11766435B2 | N3-substituted iminopyrimidinones as antimalarial agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US12350270B2 | Antimalarial agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US12338219B2 | Antimalarial agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.